Isracann Biosciences Provides Bi-Weekly Default Status Report

Stock Information for Lineage Cell Therapeutics, Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lineage Cell Therapeutics, Inc.

CSE Bulletin: Delist - Isracann Biosciences Inc. (IPOT)
CSE Bulletin: Suspensions (IPOT, TCAN)
IIROC Trading Halt - IPOT
Isracann Biosciences Announces Delay in Filing Annual Financial Statements
Isracann Bioscience Facilitated Genetics Arrive in Israel
Isracann Bioscience Facilitates Cannabis Genetics Shipment to Israel
Praesidio signs distribution agreement with Pure Integrative Pharmacy
Isracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory Board

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.